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Background: Sepsis isone of the major predictor of death in
patients with visceral leishmaniasis(VL).However, there are cur-
rently no reliable data available on bacterial sepsis in VL patients in
Ethiopia. This study aimed to assess the prevalence of bacterial sep-
sis, causative agents and their antimicrobial susceptibility patterns
and focus of infection in patients with VL.
Methods & Materials: A prospective cross sectional study
was conducted among parasitologically conﬁrmed VL patients
suspected of sepsis admitted to University of Gondar Hospital,
Northwest Ethiopia from February 2012 to May 2012.Socio-
demographic characteristics and clinical manifestations were
documented after patient interview and physical examination.
Samples (blood, urine and others as indicated) were collected and
culturedusing standard methods.Isolates were tested for antimi-
crobial susceptibility using the disc diffusionmethod.Data were
entered and analyzed using SPSS version 20.
Results: Most of the patients 81 (97.6%), 67 (80.7%), 75 (90.4%),
80 (96.4%) were febrile, tachycardic, tachypnic, and leukopenic,
respectively. The prevalence of culture conﬁrmed bacterial sep-
sis was 19.3% (16/83). The most frequently isolated organism was
Staphylococcus aureus, accounting for 11/16 (68.8%) of cases. There
was a concordance rate of 11/12 (91.6%) between bacterial iso-
lates and their susceptibility pattern between focal infections and
blood stream infections. The overall multiple resistance was 13/16
(81.3%). The highest rate of resistance was for ampicillin 11/11
(100%), and two were MRSA. Vancomycin, gentamicin and cef-
triaxone were found to be effective against most isolates. Focal
bacterial infection was showed signiﬁcant association with bac-
terial sepsis (P =0.00; Odds ratio =11.65; 95% conﬁdence interval
4.29-31.60). Factors such as sex, age, HIV status, < 200 CD4 count,
anemia, leucopenia, malnutritionand>72 hour hospital staywere
not associatedwith bacterial sepsis.
Conclusion: The prevalence of culture conﬁrmed bacterial sep-
sis was high, multiple drug resistant Staphylococcus aureus being
the frequent isolate. Focal bacterial infections are potential sources
for bacterial sepsis among VL patients. Therefore, clinicians should
give emphasis to treat VL patients with focal bacterial infection
before developing to sepsis. Rational use of antibiotics should be
practiced in order tominimize the spread of drug resistant bacteria.
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RNA-Seq reveals strain-speciﬁc immune gene
expression by epithelial cells infected with
Mycobacterium tuberculosis strains of varying
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Background: An insight into hostmechanisms, genes and path-
ways, at the molecular level, is essential for our understanding
of the host immune response to infection, especially with differ-
ent strains of M. tuberculosis. Therefore, this study was undertaken
in order to gain a better understanding of differential and strain
speciﬁc immune responses of epithelial cells during infection by
Mycobacterium tuberculosis strains of varying pathogenicity.
Methods & Materials: Transcriptomics was used to investi-
gate changes in gene expression of immune related genes by
directly sequencing RNA transcripts from pulmonary epithelial
cells infectedwith strains belonging to four different genotypes and
a Unique strain of M. tuberculosis associated with drug resistance
in KwaZulu-Natal. RNAwas extracted from infected and uninfected
epithelial cells at 48hrafter infection. The IlluminaHiSeq2000plat-
form was used to sequence 50bp reads that were mapped to the
human genome (hg19) using Tophat (2.0.10). Differential expres-
sion between the uninfected and infected cells, as well as among
the different strains, was quantiﬁed using Cufﬂinks (2.1.0).
Results: Enrichment analysis revealed differential expression of
a varying number of immune-related genes by the different strains:
F15/LAM4/KZN (KZN) (450), Beijing (319), F11 (422), F28 (325),
Unique (334) and H37Rv (383). All strains induced 178 immune
related genes in common at different levels. These included sur-
face receptors (TLRs), interleukins, cell differentiation markers and
genes involved in signalling pathways for cytokine production and
immune responsepathways. Additionally, changeswere induced in
a number of immune related genes distinct for the different strains:
KZN (49), Unique (34), H37Rv (16), F11 (14), F28 (3), Beijing (0).
Conclusion: The highly virulent Beijing strain failed to induce
genes speciﬁc to its genotype in contrast to other strains. The KZN
strain displayed the highest number of genotype-speciﬁc immune
related genes compared to the others. Strain-speciﬁc gene expres-
sion signature patterns during infection by different strains of M.
tuberculosismay reﬂect varyingpathogenicity and representpoten-
tial biomarkers that can be exploited for vaccine development.
However, this will need to be conﬁrmed in vivo.
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